nVector
nVector enables and accelerates breakthrough treatments for previously untreatable diseases of the central nervous system. Iron Horse Diagnostics, Inc. is a privately held molecular diagnostic company focused on the development and commercialization of novel tests to support the diagnosis and management of amyotrophic lateral sclerosis (ALS), traumatic brain injury (TBI), and other neurological diseases.
Company details
Find locations served, office locations
- Business Type:
- Manufacturer
- Industry Type:
- Medical Monitoring
- Market Focus:
- Nationally (across the country)
This company also provides solutions for other industrial applications.
Please, visit the following links for more info:
Welcome
Pioneered by our renowned neuroscience team, this biomarker-based ALS test is the first rapid and reliable diagnostic tool that can impel early intervention. We can now hasten the ALS diagnostic process through simple blood and CSF tests for expedited therapeutic treatment.
- Proven – Clinically tested, accurate results.
- Fast – Test results delivered in days, dramatically shortening time to treatment.
- Advanced – The first biomarker-based test on the market; a breakthrough in ALS diagnostics.
Independently tested in over 800 patients and in active clinical use in the U.S. and Europe, this rapid-result test can bring hope and earlier treatment to patients. Order tests today to accelerate your current clinical assessment process.
As a laboratory developed test (LDT) under the Centers for Medicare and Medicaid Services’ (CMS) Clinical Laboratory Improvement Amendments (CLIA), the Iron Horse ALS Test is approved for clinical use and does not require FDA clearance or approval. The Iron Horse ALS Test was developed exclusively by Iron Horse Diagnostics, Inc. Iron Horse conducts all testing in a CLIA lab certified to perform high complexity clinical laboratory testing. This test is intended as an aid in diagnostic test for ALS and is not to be regarded as being investigational or for research.